Literature DB >> 30927028

[Silver coating on tumour prostheses].

J Friesenbichler1, M Bergovec2, W Maurer-Ertl2, P Reinbacher2, M Maier2, F Amerstorfer2, A Leithner2.   

Abstract

BACKGROUND: Modular endoprostheses, so-called "tumour or megaprostheses" are mainly used for limb salvage surgery after resection of malignant soft tissue or a bone tumour. Sometimes, this type of prosthesis is also used for revision surgeries after failed primary joint arthroplasty. Despite continuously improving techniques and quality management systems, periprosthetic infection is one of the most serious complications. AIM OF THE STUDY: Review of the literature in the PubMed data base with the main focus on silver coatings in joint arthroplasty and their effect on infection rate, outcome and patients' safety.
RESULTS: The current literature shows that there is a beneficial role of silver coatings in megaprostheses in terms of revision rates for septic complications, especially following tumour resection with bad soft tissue coverage or in (multimorbid) high-risk patients, compared to uncoated implants. DISCUSSION: Based on the results of previous publications examining blood or serum silver concentrations or silver levels in urine, silver coatings do not appear to have side effects, except for local argyria. Continuous monitoring of silver levels in blood or serum is still recommended, and additional long-term studies will be necessary to verify the effectiveness and safety of silver coatings.

Entities:  

Keywords:  Agyria; Bone cancer; Endoprosthesis; Limb salvage; Revision surgery

Mesh:

Substances:

Year:  2019        PMID: 30927028     DOI: 10.1007/s00132-019-03720-x

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  24 in total

1.  Endoprosthetic reconstruction in 250 patients with sarcoma.

Authors:  Georg Gosheger; Carsten Gebert; Helmut Ahrens; Arne Streitbuerger; Winfried Winkelmann; Jendrik Hardes
Journal:  Clin Orthop Relat Res       Date:  2006-09       Impact factor: 4.176

2.  In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations.

Authors:  Christoph E Albers; Wilhelm Hofstetter; Klaus A Siebenrock; Regine Landmann; Frank M Klenke
Journal:  Nanotoxicology       Date:  2011-10-21       Impact factor: 5.913

3.  Silver-coated megaprostheses in the proximal femur in patients with sarcoma.

Authors:  Arne Streitbuerger; Marcel P Henrichs; Gregor Hauschild; Markus Nottrott; Wiebke Guder; Jendrik Hardes
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-06-20

4.  Understanding long-term silver release from surface modified porous titanium implants.

Authors:  Anish Shivaram; Susmita Bose; Amit Bandyopadhyay
Journal:  Acta Biomater       Date:  2017-05-29       Impact factor: 8.947

5.  Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas.

Authors:  M M Malawer; L B Chou
Journal:  J Bone Joint Surg Am       Date:  1995-08       Impact factor: 5.284

6.  Silver-coated megaendoprostheses in a rabbit model--an analysis of the infection rate and toxicological side effects.

Authors:  Georg Gosheger; Jendrik Hardes; Helmut Ahrens; Arne Streitburger; Horst Buerger; Michael Erren; Andreas Gunsel; Fritz H Kemper; Winfried Winkelmann; Christof Von Eiff
Journal:  Biomaterials       Date:  2004-11       Impact factor: 12.479

7.  Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels.

Authors:  M Glehr; A Leithner; J Friesenbichler; W Goessler; A Avian; D Andreou; W Maurer-Ertl; R Windhager; P-U Tunn
Journal:  Bone Joint J       Date:  2013-07       Impact factor: 5.082

8.  Lack of toxicological side-effects in silver-coated megaprostheses in humans.

Authors:  Jendrik Hardes; Helmut Ahrens; Carsten Gebert; Arne Streitbuerger; Horst Buerger; Michael Erren; Andreas Gunsel; Christian Wedemeyer; Guido Saxler; Winfried Winkelmann; Georg Gosheger
Journal:  Biomaterials       Date:  2007-03-03       Impact factor: 12.479

Review 9.  Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature.

Authors:  J Schmolders; S Koob; P Schepers; P H Pennekamp; S Gravius; D C Wirtz; R Placzek; A C Strauss
Journal:  Arch Orthop Trauma Surg       Date:  2016-10-25       Impact factor: 3.067

10.  Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery.

Authors:  F Donati; G Di Giacomo; S D'Adamio; A Ziranu; S Careri; Ma Rosa; G Maccauro
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.